Marshall Wace’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Hold
0
2843
2024
Q1
Hold
0
2600
2023
Q4
Hold
0
2423
2023
Q3
Hold
0
2484
2023
Q2
Hold
0
2694
2023
Q1
Hold
0
2794
2022
Q4
Hold
0
3007
2022
Q3
Hold
0
3266
2022
Q2
Hold
0
3346
2022
Q1
Hold
0
3542
2021
Q4
Hold
0
3711